Clinical Trial Update: To Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD) [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study to evaluate the safety, pharmacokinetics, and efficacy of GB10 injected into the eye for neovascular age-re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• GB10

Snippet

Sponsor: Shenzhen Kexing Pharmaceutical Co., Ltd. | Conditions: Neovascular Age-Related Macular Degeneration (nAMD) | Phase 1 | Status: NOT_YET_RECRUITING